Host proteins and immune system components

The term "Host proteins and immune system components" refers to the vast array of endogenous molecules and specialized proteins that constitute an organism's biological infrastructure and defense mechanisms (Janeway's Immunobiology, 2016). This category includes diverse functional groups such as cytokines, complement proteins, cell surface receptors, and intracellular enzymes that are essential for maintaining homeostasis and executing the immune response (Nature Reviews Immunology, 2018). In clinical medicine, specific host proteins are targeted to treat various conditions; for example, monoclonal antibodies may inhibit specific cytokines to reduce inflammation or block checkpoint receptors to enhance anti-tumor immunity (Nature Reviews Drug Discovery, 2017). However, as a collective term, it is too broad to represent a single therapeutic target, as it encompasses thousands of distinct entities with varying structures and biological roles. Pathogens often exploit these host proteins to gain entry into cells or evade detection, making certain host factors potential targets for anti-infective therapies (Cell, 2020). Because the term lacks molecular specificity, it does not have a single mechanism of action or a uniform safety profile. Structured pharmacological databases require the identification of specific proteins, such as Interleukin-6 or Toll-like receptor 4, rather than broad systemic categories to accurately map drug-target interactions (UniProt, 2023). Consequently, this entry is classified as an incorrect target designation due to its generic nature and lack of specific molecular identity.

Other names

Host factorsImmune system proteinsHost-defense moleculesEndogenous proteins

Varies by specific component; includes cytokine neutralization, checkpoint inhibition, and enzymatic modulation (Nature Reviews Drug Discovery, 2017).